Compare — Georgia Financials

panel 2026-09-21Ask

Peer percentile within sector

Rank on

Company	Sector	EBITDA margin · FY 2018	Percentile	Sector n
Medimex	Pharma	36.2%	88th pct	86
Med Parmasi Group	Pharma	17.8%	64th pct	86
Pip Company	Pharma	9.4%	47th pct	86
Sando Pharma	Pharma	0.3%	21st pct	86
Vit Georgia Parmi	Pharma	-4.9%	13th pct	86

Percentile is within each company's own sector across the whole FY2018 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.

FY 2018 · GEL thousands · companies ordered by revenueXLSX

Line item	Sando Pharma	Med Parmasi Group	Vit Georgia Parmi	Pip Company	Medimex
Total Current Assets	1,187	936	1,444	1,191	991
Total Non-Current Assets	55	738	282	19	10,469
TOTAL ASSETS	1,242	1,674	1,726	1,209	11,459
Total Current Liabilities	462	197	1,028	968	241
Total Non-Current Liabilities	226	190	697	6	0
TOTAL LIABILITIES	689	387	1,724	974	241
Total Equity	553	1,287	2	235	11,218
Balance Check (Assets - L&E)	0	0	0	0	0
Total Debt	226	289	1,045	0	223
Cash & Equivalents	53	12	0	3	11
Net Debt	174	277	1,045	-3	212